TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") ACQUISITION OF 32% OF THE EQUITY INTEREST IN EMEDASIA SDN BHD BY HS BIO SUPPLIES SDN BHD (FORMERLY KNOWN AS HC MSC SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY ("ACQUISITION OF 32% OF THE EQUITY INTEREST IN EMEDASIA")
| HONG SENG CONSOLIDATED BERHAD |
| Type | Announcement |
| Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS |
| Description | HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY")
ACQUISITION OF 32% OF THE EQUITY INTEREST IN EMEDASIA SDN BHD BY HS BIO SUPPLIES SDN BHD (FORMERLY KNOWN AS HC MSC SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY ("ACQUISITION OF 32% OF THE EQUITY INTEREST IN EMEDASIA") |
|
Reference is made to the announcements dated 31 December 2020, 4 January 2021, 5 February 2021, 9 February 2021 and 22 February 2021 in relation to the Acquisition of 32% of the equity interest in eMedAsia (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein.
The Board of Directors of Hong Seng wishes to announce that the 3,000,000 Consideration Shares issued and allotted to the Vendor pursuant to the Acquisition of 32% of the equity interest in eMedAsia have been listed on the Main Market of Bursa Securities on 23 February 2021 which marks that completion of the Acquisition of 32% of the equity interest in eMedAsia.
This announcement is dated 23 February 2021. |
|
Announcement Info
| Company Name | HONG SENG CONSOLIDATED BERHAD |
| Stock Name | HONGSENG |
| Date Announced | 23 Feb 2021 |
| Category | General Announcement for PLC |
| Reference Number | GA1-23022021-00079 |